 This study aimed to develop a novel injectable hydrogel containing cinemalvahide, CN, for the treatment of diabetic foot ulcers. The hydrogel was composed of chitosan, CHT, and beta-cyclodextrin, PCD, which showed excellent biocompatibility and antimicrobial activity against staphylococcus aureus and pseudomonas aeroginosa. Additionally, the hydrogel exhibited increased elasticity when combined with CN, suggesting that it may have potential for use in treating DFUs. This article was authored by Henry Chichkyapasafloris, Nicholas Tabari, Phong Chai and others.